Acta Haematologica
Overview
Acta Haematologica is a peer-reviewed medical journal that focuses on the study of blood and blood disorders. It publishes original research articles, reviews, and case reports related to hematology, including hematopoiesis, hematological malignancies, transfusion medicine, and coagulation disorders. The journal serves as a valuable resource for hematologists, oncologists, and researchers interested in advancing knowledge and understanding in the field of hematology.
Details
Details
Abbr.
Acta Haematol
Start
1948
End
Continuing
Frequency
Eight no. a year
p-ISSN
0001-5792
e-ISSN
1421-9662
Country
Switzerland
Language
English
Specialty
Hematology
Metrics
Metrics
h-index / Ranks: 5907
62
SJR / Ranks: 6492
686
CiteScore / Ranks: 5214
4.90
JIF / Ranks: 4480
2.4
Recent Articles
11.
Thompson J, Grose R, Yeung D, White D
Acta Haematol
. 2025 Jan;
:1-5.
PMID: 39761655
Introduction: ETV6::JAK2 is a fusion known to drive acute lymphoblastic leukaemia (ALL) in the presence of other genomic lesions which define the JAK/STAT class of Philadelphia chromosome-like acute lymphoblastic leukaemia...
12.
Loap P, Kirova Y
Acta Haematol
. 2025 Jan;
:1-7.
PMID: 39756374
Introduction: Anal lymphoma (AL) is a rare presentation of extranodal lymphomas, characterized by occurrence in the anal area and largely understudied due to its infrequency. This study aimed to address...
13.
Novel Approaches of Cellular Therapy in Multiple Myeloma: Focus on Chimeric Antigen Receptor T-Cells
Narra R, Peshin S, Dhakal B
Acta Haematol
. 2024 Dec;
:1-16.
PMID: 39733769
Background: Recent advancements in cellular therapies, particularly chimeric antigen receptor T-cells (CAR-T) and T-cell-engaging bispecific antibodies have significantly altered the therapeutic landscape for multiple myeloma. There are two US FDA...
14.
Goldberg I, Spectre G, Raanani P, Ten Cate H, Leader A
Acta Haematol
. 2024 Dec;
1-17.
PMID: 39662064
Background: Managing cancer-associated thrombosis (CAT) is a significant clinical challenge due to several factors such as increased bleeding tendency, frailty, and drug-drug interactions. For many years, the drug of choice...
15.
Itchaki G, Benjamini O, Levi M, Nemets A, Ygna S, Assaly M, et al.
Acta Haematol
. 2024 Dec;
1-6.
PMID: 39631372
Introduction: Waldenström macroglobulinemia (WM) is a rare indolent lymphoma. Zanubrutinib (ZAN), a second-generation BTK inhibitor, has been approved for the treatment of WM in any line of therapy in 2021....
16.
17.
Aslam M, Cheema A, Shahid D, Maryam B, Mukhopadhyay D, Munir M, et al.
Acta Haematol
. 2024 Nov;
:1-15.
PMID: 39586285
Background: Advances in novel therapies have improved outcomes for multiple myeloma (MM) patients and the use of allo-SCT has decreased. Current guidelines no longer support allo-SCT as consolidation therapy for...
18.
Itzhaki Ben Zadok O, Vaxman I, Hoss S, Talmor-Barkan Y, Steinmetz T, Raanani P, et al.
Acta Haematol
. 2024 Nov;
:1-10.
PMID: 39586273
Introduction: The prevalence of preexisting obstructive coronary artery disease (CAD) and the occurrence of anginal chest pain as a presenting symptom in patients with light-chain (AL) and transthyretin (ATTR) cardiac...
19.
Kulagin A, Ptushkin V, Lukina E, Davydkin I, Korobkin A, Konstantinova T, et al.
Acta Haematol
. 2024 Nov;
1-9.
PMID: 39586236
Introduction: The study aimed to assess the safety, immunogenicity, and efficacy of long-term therapy with biosimilar of eculizumab (Elizaria®) in paroxysmal nocturnal hemoglobinuria (PNH) patients. Methods: The study included 30...
20.
Klotzer C, Schnabel F, Kubasch A, Jentzsch M, Franke G, Uhlig J, et al.
Acta Haematol
. 2024 Oct;
:1-5.
PMID: 39467528
Introduction: Thiamine-responsive megaloblastic anemia syndrome (TRMA) is a rare autosomal recessive disease with a homozygous or compound-heterozygous mutation in the SLC19A2 gene characterized by megaloblastic anemia, diabetes mellitus (DM), and...